Relevance of Laparoscopic Surgery for Ovarian Cancer in Well-selected Patients: A Propensity-matched Comparison With Laparotomy
暂无分享,去创建一个
L. Lecointre | C. Akladios | M. Pellerin | E. Faller | T. Boisramé | F. Jochum | Gabrielle Aubry | Camille Billard
[1] L. Lecointre,et al. Three and Five-Year Mortality in Ovarian Cancer after Minimally Invasive Compared to Open Surgery: A Systematic Review and Meta-Analysis , 2020, Journal of clinical medicine.
[2] D. Timmerman,et al. ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.
[3] A. Secord,et al. Surgical complexity score and role of laparoscopy in women with advanced ovarian cancer treated with neoadjuvant chemotherapy. , 2019, Gynecologic oncology.
[4] G. Scambia,et al. The INTERNATIONAL MISSION study: minimally invasive surgery in ovarian neoplasms after neoadjuvant chemotherapy , 2019, International Journal of Gynecologic Cancer.
[5] P. Ramirez. Interval cytoreduction for advanced ovarian cancer: is minimally invasive surgery ready for the next prospective randomized trial? , 2019, International Journal of Gynecological Cancer.
[6] Jubilee Brown,et al. When Less Is More: Minimally Invasive Surgery Compared with Laparotomy for Interval Debulking After Neoadjuvant Chemotherapy in Women with Advanced Ovarian Cancer. , 2018, Journal of minimally invasive gynecology.
[7] V. Gebski,et al. Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer , 2018, The New England journal of medicine.
[8] S. Uccella,et al. Laparoscopy for primary cytoreduction with multivisceral resections in advanced ovarian cancer: prospective validation. “The times they are a-changin”? , 2018, Surgical Endoscopy.
[9] G. Bogani,et al. Laparoscopy Compared With Laparotomy for Debulking Ovarian Cancer After Neoadjuvant Chemotherapy. , 2017, Obstetrics and gynecology.
[10] M. Berry,et al. Reporting and Guidelines in Propensity Score Analysis: A Systematic Review of Cancer and Cancer Surgical Studies , 2017, Journal of the National Cancer Institute.
[11] G. Bogani,et al. Minimally Invasive Surgical Staging for Ovarian Carcinoma: A Propensity-Matched Comparison With Traditional Open Surgery. , 2017, Journal of minimally invasive gynecology.
[12] G. Scambia,et al. Minimally invasive versus standard laparotomic interval debulking surgery in ovarian neoplasm: A single-institution retrospective case-control study. , 2016, Gynecologic oncology.
[13] T. Lawrie,et al. Laparoscopy versus laparotomy for FIGO stage I ovarian cancer. , 2016, The Cochrane database of systematic reviews.
[14] J. Black,et al. The role of minimally invasive interval debulking surgery in advanced epithelial ovarian cancer , 2016, Expert review of anticancer therapy.
[15] B. Ataseven,et al. Prognostic Impact of Port-Site Metastasis After Diagnostic Laparoscopy for Epithelial Ovarian Cancer , 2016, Annals of Surgical Oncology.
[16] W. Kuhn,et al. Impact of Open Laparoscopy in Patients Under Suspicion of Ovarian Cancer. , 2016, Anticancer research.
[17] Chongdong Liu,et al. Comparison of Laparoscopy and Laparotomy in Surgical Staging of Apparent Early Ovarian Cancer , 2016, Medicine.
[18] G. Scambia,et al. Current Recommendations for Minimally Invasive Surgical Staging in Ovarian Cancer , 2016, Current Treatment Options in Oncology.
[19] W. Gotlieb,et al. Laparoscopic and robot-assisted hysterectomy for uterine cancer: a comparison of costs and complications. , 2015, American journal of obstetrics and gynecology.
[20] C. Köhler,et al. Oncologic Concerns regarding Laparoscopic Cytoreductive Surgery in Patients with Advanced Ovarian Cancer Submitted to Neoadjuvant Chemotherapy , 2015, Oncology.
[21] M. Gasparri,et al. Implementation of laparoscopic approach for type B radical hysterectomy: a comparison with open surgical operations. , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[22] Ying Zhang,et al. Effect of CO2 pneumoperitoneum on the proliferation of human ovarian cancer cell line SKOV-3 and the expression of NM23-H1 and MMP-2 , 2015, Archives of Gynecology and Obstetrics.
[23] F. Ghezzi,et al. Laparoscopic and Open Abdominal Staging for Early-Stage Ovarian Cancer: Our Experience, Systematic Review, and Meta-analysis of Comparative Studies , 2014, International Journal of Gynecologic Cancer.
[24] M. Leeflang,et al. Laparoscopy for diagnosing resectability of disease in patients with advanced ovarian cancer. , 2014, The Cochrane database of systematic reviews.
[25] G. Scambia,et al. Introduction of staging laparoscopy in the management of advanced epithelial ovarian, tubal and peritoneal cancer: impact on prognosis in a single institution experience. , 2013, Gynecologic oncology.
[26] P. Austin,et al. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies , 2010, Pharmaceutical statistics.
[27] Young Tae Kim,et al. Comparisons of Surgical Outcomes, Complications, and Costs Between Laparotomy and Laparoscopy in Early-Stage Ovarian Cancer , 2010, International Journal of Gynecologic Cancer.
[28] W. Cliby,et al. Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer. , 2007, American journal of obstetrics and gynecology.
[29] N. Demartines,et al. Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.
[30] J. Hurteau,et al. Effect of carbon dioxide on human ovarian carcinoma cell growth. , 2001, American journal of obstetrics and gynecology.
[31] M. Canis,et al. Tumor growth and dissemination after laparotomy and CO2 pneumoperitoneum: a rat ovarian cancer model. , 1998, Obstetrics and gynecology.